Skip to main content

Virtual Molecular Rounds

March to December, 2024

VMR’S HOME   |   FACULTY   |   SPONSORS   |   RECORDED SESSIONS

Next Round: Thursday, January 23, 2025

REGISTER NOW!

WELCOME TO POET MOLECULAR ROUNDS

POET National Virtual Molecular Rounds is a one hour monthly educational program which takes place at 11 AM MT/ 10 AM PT / 1 PM ET/ 2 PM ATL.

POET is an academic program based out of the University of Calgary focused on Precision Oncology biomarker discovery, registries and access to novel diagnostics and therapeutics. POET strives to have accessible education across Canada for health care clinicians about molecular diagnostics and advancements in precision oncology biomarker driven practice.

By the end of the webinar series, each audience member will have the opportunity to:

  1. Learn the latest developments in molecular oncology and precision medicine through world-renowned speakers.
  2. Discuss and understand approaches to the challenging clinical interpretation of comprehensive genomic profile results shared among experts.
  3. Discuss areas of controversy and the challenges of molecular and polyomic diagnostics in relation to biomarker driven precision oncology therapeutics.

We look forward to this very informative virtual webinar series.

Best regards,

Dr. Pinaki Bose
Scientific Lead, POET Molecular Rounds

Dr. Steven Yip
Medical Lead, POET Molecular Rounds

Dr. Vishal Navani,
Principal POET Ambassador,
Virtual Molecular Rounds 

AGENDA

Thursday, January 23, 2025
(Times listed in Mountain Time)
11:00 AM – 11:05 AM Welcome Remarks Dr. Steven Yip & Dr. Vishal Navani, POET VMR Co-Chairs
11:05 AM – 11:50 AM Integrating Clinical Trial and Real World Evidence to Improve Patient Access to Targetable Drugs in North America: Experiences in ALK and ROS1

 

Learning Objectives:

  1. To recognize how both clinical trial and observational data are used during the regulatory
    and funding evaluation phases of lung cancer targeted therapies.
    2. To cite examples of real world data used to support the eventual funding of targeted
    agents in lung cancer.
    3. To describe examples of targeted drug access programs that integrate real world data
    collection to improve patient drug access.
Geoffrey Liu, MSc, MD
Senior Scientist, Princess Margaret Cancer Centre Toronto, ON
11:50 AM – 11:55 AM Panel Discussion Dr. Geoffrey Liu, Dr. Steven Yip, Dr. Pinaki Bose & Dr. Vishal Navani
11:55 AM – 12:00 PM Audience Questions & Answers
12:00 AM Closing Remarks Dr. Pinaki Bose & Dr. Steven Yip, POET Chairs
REGISTER NOW!